Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study

Figure 3

(a) Plasma γ-GT level at baseline, 12 weeks, and 24 weeks and changes in γ-GT level from baseline to 24 weeks. (b) Plasma AST level at baseline, 12 weeks, and 24 weeks and changes in AST level from baseline to 24 weeks. (c) Plasma ALT level at baseline, 12 weeks, and 24 weeks and changes in ALT level from baseline to 24 weeks. (d) IR index level at baseline, 12 weeks, and 24 weeks and changes from baseline to 24 weeks. AST: aspartate aminotransferase; ALT: alanine aminotransferase; IR: insulin resistance index; ns: no significance. I bars and T bars denote standard deviations. , , , and .

(a)

(b)

(c)

(d)